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Introduction
Cancer is one of the most important health problems 
in the world. In developed countries, 55 % of the burden 
of diseases is associated with cancer (Ferlay et al., 
2010a). The incidence of cancer is rapidly increasing 
in the developing world (Youlden et al., 2014). Breast 
cancer is the most common cancer in women. More 
than 1.3 million patients suffering from the cancer are 
diagnosed each year in the world (Grayson, 2012). More 
than 508,000 women in the world have lost their lives 
due to breast cancer in 2011. The incidence of breast 
cancer varies from 89.7 per 100,000 in East Africa to 
19.4 per 100,000 people in West Europe (WHO, 2015a). 
Breast cancer is the most common malignancies in Asian 
women (Grayson, 2012). This is increasing in Asian 
countries with a sharp slope (Keyghobadi et al., 2015). 
Although the incidence rate is lower in Asian countries 
than in Europe and the United States, the death rate 
from breast cancer is considerable in Asia (Jemal et al., 
2011). A history of cancer registration is very different in 
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Abstract
 Purpose: This study aimed to investigate the incidence and mortality of breast cancer, and its relationship 
with human development index (HDI) and its components in Asia in 2012. Materials and Methods: This study 
was an ecologic study in Asia for assessment of the correlation between age-specific incidence rate (ASIR) and 
age-specific mortality rate (ASMR) with HDI and its details that include: life expectancy at birth, mean years 
of schooling and gross national income (GNI) per capita. Data about SIR and SMR for every Asian country for 
the year 2012 were obtained from the global cancer project. We used a bivariate method for assessment of the 
correlation between SIR and SMR and HDI and its individual components. Statistical significance was assumed 
if P<0.05. All reported P-values are two-sided. Statistical analyses were performed using SPSS (Version 15.0, 
SPSS Inc.). Results: In 2012, 639,824 cases of breast cancer were recorded in Asian countries. Countries with 
the highest standardized incidence rate (ASIR) (per 100,000) were Israel (80.5), Lebanon (78.7), Armenia (74.1) 
and the highest standard mortality rate (ASMR) was observed in Pakistan (25.2), Armenia (24.2), and Lebanon 
(24). There was a positive correlation between the ASIR of breast cancer and HDI (r = 0.556, p <0.001), whereas 
there was a negative correlation between the ASMR of breast cancer and HDI (r = -0.051). Conclusions: Breast 
cancer incidence in countries with higher development is greater, while mortality is greatest in countries with less 
development. There was a positive and significant relationship between the ASIR of breast cancer and HDI and 
its components. Also there was a negative but non significant relationship between the ASMR of breast cancer 
and HDI. 
Keywords: Breast cancer - human development index - incidence - mortality - Asia 
RESEARCH ARTICLE
Incidence and Mortality of Breast Cancer and their Relationship 
to Development in Asia
Mahshid Ghoncheh1, Abdollah Mohammadian-Hafshejani2, Hamid Salehiniya3, 4*
Asian countries (Shin et al., 2012). Most Asian countries 
emit reports on the incidence rate of the cancer, which 
are arguable their coverage and accuracy (Ferlay et al., 
2010b). Studies showed that preventive programs are 
better if they will be applied in any region for the most 
common cancers. Population-based cancer registration is 
suggested for control of cancer (Roshandel et al., 2014). 
Studies also revealed that early detection of the cancer is 
important in reducing the mortality rate and improving 
prognosis (Rahimzadeh et al., 2014). The survival rate 
is different in the world, in the North of United States 
more than 80% and in low income countries less than 
40%. The low survival in not developed countries is more 
related to lack of diagnostic and screening programs and 
treatment facilities (WHO, 2015a).The residence area and 
socio-economic status are also associated with the stage 
of cancer diagnosis (Abbastabar et al., 2013). According 
to studies performed, low percentage of population has 
well know awareness of effective factors in developing 
cancer and diagnostic procedures (Ray and Mandal, 
2004). Low educated mothers seek lower treatment 
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facilities (Ramadas et al., 2015). A direct relationship was 
observed between women’s information and acquiring 
their healthy behaviors, such as breast examination (Chen 
et al., 2014). Low information in women, low budget, and 
lack of insurance and screening programs are problems 
in implementation of cancer prevention and treatment 
programs n Asia (Agarwal et al., 2007). In some Asian 
countries, like Hong Kong, South Korea, Taiwan, and 
Thailand, effective screening programs are implemented 
(Sankaranarayanan et al., 2014).
To investigate conditions of countries, indicators have 
been defined. One of the most important indicators is the 
Human Development Index (HID), which assesses the 
condition or status of a country based on three fundamental 
aspects. The indicator is combination of lifetime, 
knowledge, and the standards of living. Lifetime is 
measured by life expectancy at birth, knowledge by years 
of potential education, and adequate standard of living 
by GDP per capita or income. HDI is a number between 
zero and one. According to HDI, countries in the world 
are divided into four categories: Countries with very high 
HDI (HDI≥0.9), countries with a high HDI (HDI≥0.8), 
Medium HDI countries (0.8> HDI>0.5), and countries 
with a low HDI (HDI≤0.5). The index was proposed by 
UNDP in 1990 as an indicator of comparison of countries 
in three human aspects. HDI was announced in 2013 on 
average in Arabic countries 0.682, East Asia and Pacific 
0.703, and South Asia 0.588. The average of the indicator 
in some Asian countries is lower than the global average 
(0.702) (UNDP, 2014)
Chronic diseases such as breast cancer have many 
causes. A number of studies have mentioned the role 
of HDI associated with the incidence and mortality of 
breast cancer (Gonzaga et al., 2015). Information on the 
incidence and mortality of breast cancer can be useful for 
planning health and research activities. According to the 
possible impact of HDI, this study aimed to investigate 
the incidence and mortality of breast cancer, and its 
relationship with HDI and its components in Asia in 2012.
Materials and Methods
This study was an ecologic study in Asia for 
assessment the correlation between age-specific incidence 
rate (ASIR) and age-specific mortality rate (ASMR) with 
Human Development Index (HDI) and its details that 
include: Life expectancy at birth, Mean years of schooling 
and gross national income (GNI) per capita. Data about 
the age-specific incidence and mortality rate (ASIR) for 
every Asian counter for year 2012 get from global cancer 
project that available in (http://globocan.iarc.fr/Default.
aspx) (Ferlay, 2013)and Human Development Index (HDI) 
from Human Development Report 2013 that include 
information about HDI and its details for every country 
in the word for year 2012 (Malik, 2013). 
Method of estimate the age-specific Incidence and 
mortality rates in global cancer project by international 
agency for research on cancer 
Age-specific incidence rate (ASIR)
The methods of estimation are country specific and 
the quality of the estimation depends upon the quality 
and on the amount of the information available for each 
country. In theory, there are as many methods as countries, 
and because of the variety and the complexity of these 
methods, an overall quality score for the incidence and 
mortality estimates combined is almost impossible to 
establish. However an alphanumeric scoring system which 
independently describes the availability of incidence 
and mortality data has been established at the country 
level. The combined score is presented together with the 
estimates for each country with an aim of providing a 
broad indication of the robustness of the estimation.
The methods to estimate the sex- and age-specific 
incidence rates of cancer for a specific country fall into 
one of the following broad categories, in priority order:
1- Rates projected to 2012 (38 countries)-2- Most 
recent rates applied to 2012 population (20 countries)-
3-Estimated from national mortality by modelling, using 
incidence mortality ratios derived from recorded data 
in country-specific cancer registries (13 countries)-4- 
Estimated from national mortality estimates by modelling, 
using incidence mortality ratios derived from recorded 
data in local cancer registries in neighboring countries (9 
European countries)-5-Estimated from national mortality 
estimates using modelled survival (32 countries)-6- 
Estimated as the weighted average of the local rates 
(16 countries)-7- One cancer registry covering part of a 
country is used as representative of the country profile (11 
countries)-8-Age/sex specific rates for “all cancers” were 
partitioned using data on relative frequency of different 
cancers (by age and sex) (12 countries)-9- The rates are 
those of neighboring countries or registries in the same 
area (33 countries) (Ferlay, 2013)
Age-specific mortality rate (ASMR)
Depending of the degree of detail and accuracy of the 
national mortality data, six methods have been utilized 
in the following order of priority: 1-Rates projected to 
2012 (69 countries)-2- Most recent rates applied to 2012 
population (26 countries)-3- Estimated as the weighted 
average of regional rates (1 country)-4- Estimated 
from national incidence estimates by modelling, using 
country-specific survival (2 countries)-5-Estimated from 
national incidence estimates using modelled survival (83 
countries)-6-The rates are those of neighboring countries 
or registries in the same area (3 countries)
Human development index (HDI)
Human Development Index (HDI), a composite 
measure of indicators along three dimensions: life 
expectancy, educational attainment and command over 
the resources needed for a decent living. All groups 
and regions have seen notable improvement in all HDI 
components, with faster progress in low and medium 
HDI countries. On this basis, the world is becoming 
less unequal. Nevertheless, national averages hide large 
variations in human experience. Wide disparities remain 
within countries of both the North and the South, and 
income inequality within and between many countries 
has been rising (Malik, 2013).
Statistical analysis: In this study, we use of correlation 
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bivariate method for assessment the correlation between 
ASIR and ASMR with HDI and its details that include Life 
expectancy at birth, Mean years of schooling and Gross 
national income (GNI) per capita. Statistical significance 
was assumed if P<0.05. All reported P-values are two-
sided. Statistical analyses were performed using SPSS 
(Version 15.0, SPSS Inc.).
Results 
In 2012, 639,824 cases of breast cancer were recorded 
in Asian countries. Five Asian countries with the highest 
number of cases were China (187,213 cases), India 
(144,937 cases), Japan (55,710 cases), Indonesia (48,998 
cases, and Pakistan (34,038 cases), respectively. The five 
countries included 470,896 cases (59/73%) of the cases 
in Asia. 
In Asian countries, 5 countries with the highest 
standardized incidence rate of breast cancer (per 100,000) 
were Israel (80.5), Lebanon (78.7), Armenia (74.1), 
Singapore (65.7), and Kazakhstan (73.5), respectively. 
Five countries that had the lowest standardized incidence 
rate of breast cancer (per 100,000) included Butane 
(4.6), Mongolia (9.4), Nepal (13.7), Lao PDR (19), and 
Cambodia (19.3), respectively (Table1, Fgure1, Map1). 
In 2012, 228,926 deaths occurred due to breast cancer 
in Asia. The highest number of deaths was observed in 
India, (70,218 cases), China (47,984 cases), Indonesia 
Table 1. Incidence and Mortality of breast Cancer in Asia by Country
Country Numbers Crude Rate ASIR  country Numbers Crude Rate ASMR 
Israel 4010 103.0 80.5 Pakistan 16232 18.3 25.2
Lebanon 1934 88.0 78.7 Armenia 609 36.7 24.2
Armenia 1704 102.5 74.1 Lebanon 599 27.3 24.0
Singapore 2524 96.8 65.7 Jordan 426 13.6 21.8
Kazakhstan 6252 73.5 63.0 Syrian Arab Republic 1623 15.6 21.5
Jordan 1237 39.4 61.0 Afghanistan 1695 10.5 20.6
Syrian Arab Republic 4140 39.7 52.5 Iraq 1983 11.8 19.3
Korea, Republic of 17140 70.3 52.1 Malaysia 2572 17.8 18.9
Japan 55710 85.9 51.5 State of Palestine 223 10.6 18.3
Pakistan 34038 38.4 50.3 Kazakhstan 1865 21.9 18.0
Brunei 83 40.6 48.6 Philippines 6621 13.8 17.8
Philippines 18327 38.1 47.0 Kuwait 103 8.8 17.3
Kuwait 314 26.9 46.7 Israel 990 25.4 17.3
Qatar 148 31.6 46.1 Indonesia 19750 16.1 16.6
State of Palestine 578 27.5 44.0 Timor-Leste 52 8.9 16.4
Georgia 1541 67.7 44.0 Singapore 628 24.1 15.5
Iraq 4542 27.1 42.6 Yemen 997 7.9 14.9
Bahrain 177 34.7 42.5 Korea, Democratic Republic of 2340 18.7 14.3
Indonesia 48998 39.9 40.3 Turkey 5199 13.9 13.4
United Arab Emirates 568 22.8 39.2 Georgia 530 23.3 13.2
Turkey 15230 40.8 39.1 India 70218 11.5 12.7
Malaysia 5410 37.4 38.7 Maldives 14 8.7 11.5
Korea, Democratic Republic of 5707 45.7 36.8 Brunei 18 8.8 11.3
Afghanistan 3108 19.3 35.1 Myanmar 2792 11.3 11.3
Timor-Leste 108 18.6 32.6 Kyrgyzstan 265 9.6 11.2
Maldives 41 25.5 31.6 Qatar 31 6.6 11.2
Sri Lanka 3955 36.8 30.9 Bahrain 42 8.2 11.1
Saudi Arabia 2791 21.7 29.5 Bangladesh 7142 9.5 11.0
Thailand 13653 38.4 29.3 Thailand 5092 14.3 11.0
Iran, Islamic Republic of 9795 26.3 28.1 Uzbekistan 1269 9.0 10.6
Yemen 1963 15.5 27.4 United Arab Emirates 124 5.0 10.5
Kyrgyzstan 662 24.0 27.3 Sri Lanka 1361 12.6 10.3
Uzbekistan 3370 23.9 27.1 Viet Nam 4671 10.3 9.9
Turkmenistan 656 25.0 26.8 Iran, Islamic Republic of 3304 8.9 9.9
Oman 195 16.4 26.0 Japan 13801 21.3 9.8
India 144937 23.8 25.8 Turkmenistan 224 8.5 9.6
Azerbaijan 1413 29.7 25.4 Oman 65 5.5 9.5
Viet Nam 11067 24.4 23.0 Cambodia 585 7.9 9.3
China 187213 28.6 22.1 Lao PDR 222 7.0 9.3
Myanmar 5648 22.9 22.1 Saudi Arabia 795 6.2 9.1
Bangladesh 14836 19.7 21.7 Tajikistan 210 5.8 8.7
Tajikistan 520 14.4 20.4 Azerbaijan 471 9.9 8.6
Cambodia 1255 17.0 19.3 Nepal 865 5.5 7.2
Lao PDR 472 14.8 19.0 Korea, Republic of 2274 9.3 6.1
Nepal 1716 11.0 13.7 China 47984 7.3 5.4
Mongolia 125 8.7 9.4 Mongolia 50 3.5 4.2
Bhutan 13 3.7 4.6 Bhutan 5 1.4 1.8
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(19,750 cases), Pakistan (16,232 cases), and Japan (13,801 
cases), respectively. A total of 167,985 cases (73.37%) of 
the deaths occurred in just five countries.
In Asian countries, 5 countries with the highest 
standardized death rates (per 100,000) from breast 
cancer were Pakistan (25.2), Armenia (24.2), Lebanon 
(24), Jordan (21.8), and Syria (21.5), respectively. Five 
countries have the lowest standardized mortality from 
breast cancer (per 100,000) included Butane (1.8), 
Mongolia (4.2), China (5.4), Republic of Korea (1.6), 
and Nepal (2.7), respectively (Figure 1, Table1, Map 2).
Amounts related to HDI and each of its components 
(life expectancy at birth in 2012, the average years of 
schooling in 2010, and the level of income for each one 
of the country’s population in 2012) for each of the Asian 
countries is shown in Table 2. 
There was a positive correlation of 0.556 between 
the standardized incidence rate of breast cancer and 
HDI. This relationship was statistically significant (p 
<0.001). Positive correlation was also observed between 
the components of HDI and the standardized incidence 
rate. Positive correlation was 0.443 (p=0.002) between the 
standardized incidence rate and life expectancy at birth, 
0.497 (p<0.001) between the standardized incidence rate 
and the average years of schooling, and 0.364 (p=0.013) 
between the standardized incidence rate and the level of 
income for each one of the country’s population (Figure 2). 
On the other hand, there was a negative correlation of 
Figure 2. Correlation between HDI and Standardized 
Incidence of breast cancer in Asia in 2012
	  
Map 1: Distribution of the standardized incidence rate 
of breast cancer in Asia in 2012; Map 2: Distribution 
of standardized breast cancer mortality rates in Asia 
in 2012
	  
Map1
	  
Map2
Figure 3. Correlation between HDI and Standardized 
breast Cancer mortality rates in Asia in 2012
	  
Figure 1. Incidence and Mortality of breast Cancer in 
Asia by Country
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0.051 between the standardized mortality rate of breast 
cancer and HDI. This relationship was not statistically 
significant (p=0.736). Negative and no significant 
correlation was 0.099 (p=0.514) between the standardized 
mortality rate and life expectancy at birth, 0.025 (p<0.871) 
between the standardized mortality rate and the average 
years of schooling, and 0.065 (p = 0.669) between the 
standardized mortality rate and the level of income for 
each one of the country’s population (Figure3). 
Discussion
The incidence of cancer is increasing in the developing 
countries (Youlden et al., 2014). Nearly 60% of the world’s 
population lives in Asia. It should be considered the causes 
of incidence and mortality in the continent. Lifestyle 
changes in Asian countries could be a predisposing factor 
for cancer (Kamarudin et al., 2006).
Our findings showed that the incidence of cancer in 
Asia was related to HDI, which evaluates the average 
achievements in a country in three human dimensions 
(the long life, access to knowledge, and the standard 
of adequate living. Among Asian countries¸ Israel, 
Lebanon, Armenia, Singapore, and Kazakhstan had 
most standardized cancer incidence. In these countries, 
HDI was a range from too high, high, and moderate. In 
Table 2. HDI and Its Component in Asian Country
Country Human Development Life expectancy Mean Year Gross national
 Index(HDI) at birth of schooling income (GNI) 
    per capita
Pakistan 0.515 65.7 4.9 2566
Armenia 0.729 74.4 10.8 5540
Lebanon 0.745 72.8 7.9 12364
Jordan 0.7 73.5 8.6 5272
Syrian Arab Republic 0.648 76 5.7 4674
Afghanistan 0.374 49.1 3.1 1000
Iraq 0.59 69.6 5.6 3557
Malaysia 0.769 74.5 9.5 13676
State of Palestine 0.67 73 8 3359
Kazakhstan 0.754 67.4 10.4 10451
Philippines 0.654 69 8.9 3752
Kuwait 0.79 74.7 6.1 52793
Israel 0.900 81.9 11.9 26224
Indonesia 0.629 69.8 5.8 4154
Timor-Leste 0.576 62.9 4.4 5446
Singapore 0.895 81.2 10.1 52613
Yemen 0.458 65.9 5.3 928
Korea, Democratic Republic of - - - -
Turkey 0.722 74.2 6.5 13710
Georgia 0.745 73.9 12.1 5005
India 0.554 65.8 4.4 3285
Maldives 0.688 77.1 5.8 7478
Brunei 0.855 78.1 8.6 45690
Myanmar 0.498 65.7 3.9 1 817
Kyrgyzstan 0.622 68 9.3 2009
Qatar 0.834 78.5 7.3 87478
Bahrain 0.796 75.2 9.4 19154
Bangladesh 0.515 69.2 4.8 1785
Thailand 0.69 74.3 6.6 7722
Uzbekistan 0.654 68.6 10 3201
United Arab Emirates 0.818 76.7 8.9 42716
Sri Lanka 0.715 75.1 9.3 5170
Viet Nam 0.617 75.4 5.5 2970
Iran, Islamic Republic of 0.742 73.2 7.8 10695
Japan 0.912 83.6 11.6 32545
Turkmenistan 0.698 65.2 9.9 7782
Oman 0.731 73.2 5.5 24092
Cambodia 0.543 63.6 5.8 2095
Lao PDR 0.543 67.8 4.6 2435
Saudi Arabia 0.782 74.1 7.8 22616
Tajikistan 0.622 67.8 9.8 2119
Azerbaijan 0.734 70.9 11.2 8153
Nepal 0.463 69.1 3.2 1137
Korea, Republic of 0.909 80.7 11.6 28231
China 0.699 73.7 7.5 7945
Mongolia 0.675 68.8 8.3 4245
Bhutan 0.538 67.6 2.3 5246
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contrast, low incidence was observed in countries such as 
Bhutan, Mongolia, Nepal, Cambodia, and Tajikistan with 
low and medium HDI. Life expectancy at birth is one of 
HDI dimensions. It is directly related to the incidence of 
cancer as well as breast cancer. The risk of chronic diseases 
such as cancer increases along with the development of 
a country, the removal of competing causes of death, and 
life time increased. This can be associated with increasing 
the exposure time in individuals (Ferlay et al., 2010a). In 
some Asian countries, the incidence of breast cancer in 
urban areas is significantly more than rural areas. This 
may be due to changing lifestyles (Ferlay et al., 2010b).
One of the aspects of HDI is access to knowledge. 
Studies have shown the positive relationship between 
knowledge and individuals’ behavior (Chen et al., 2014). 
With increasing knowledge, education, and employment, 
women are more likely to carry breast self-examination 
and search for diagnostic methods significantly increases 
(Ceber et al., 2013). Therefore, in these countries breast 
cancer is diagnosed much earlier than countries with lower 
levels of knowledge.
The appropriate life with a gross national income 
is another aspect of HDI (UNDP, 2014). According to 
the report of World Health Organization (WHO), with 
increasing income and improving living standards in 
developing countries, the incidence of breast cancer 
increases. This may be due to longer life, higher exposure 
to risk factors, eating more fatty foods and obesity, 
and lower pregnancy rates(WHO, 2013). In high-
income countries, taking advantage of better diagnostic 
methods significantly is different from other countries 
(Abbastabar et al., 2013). Bray et al. found that positive 
correlation between HDI and cancer. With the increasing 
development, the incidence of cancers such as breast 
cancer increases and cancers associated with infectious 
agents reduced (Bray et al., 2012). An ecologic study 
showed that there is a significant relationship between 
nutritional factors such as consumption of fish and fruit 
with breast cancer. Multiple linear regression analysis 
indicated a significant correlation between the percentage 
of university education and fruits and fish consumption. 
The study concluded that dairy consumption, nutritional 
factors, health indicators, university education, and certain 
conditions, such as diabetes mellitus, are effective on the 
incidence of breast cancer (WHO, 2015a).
Mortality rate of breast cancer is different in Asia 
(from from 25.02 in Bhutan to 08.01 in Pakistan). The 
Highest standardized mortality rates occurred in Pakistan, 
Armenia, Lebanon, Jordan, and Syria, with moderate 
HDI. Countries with high incidence do not experience 
higher mortality. There was a negative linear relationship 
between mortality rate and HDI. A negative correlation 
also observed between HDI components (life expectancy 
at birth, the average years of schooling, and the level of 
income) and standardized mortality rate. Gonzaga et al. 
there was a significant relationship between HDI and 
cancer mortality (Gonzaga et al., 2015).
 In Pakistan, for example, with the highest standardized 
death rate from breast cancer, cancer was in the eighth 
rank in the country’s burden of disease, while factors 
such as maternal and infant mortality and death from 
infectious, respiratory, and nutritional diseases are still 
the main cause of death. In the country, standardized 
death rate from breast cancer than other cancers is higher. 
In this country, the lack of public access to radiotherapy 
services in the health system can be significant. A small 
number of medical centers than the general population is 
also important(WHO, 2015b). According to the logistic 
regression after adjusting for age, marital status, and a 
family history, there was a significant relationship between 
economic, social, and educational levels and the stage of 
breast cancer in Iran (Roshandel et al., 2014). 
This was an ecological study. The ecological fallacy 
will occur if results are inferred and concluded at the 
individual level. The results of this study are attributable 
only at the population level.
Cancer incidence in countries with higher development 
is more, while mortality in countries with less development 
is more. There was a positive and significant relationship 
between the standardized incidence rate of breast cancer 
and HDI aspects (life expectancy at birth, the average 
years of schooling, and the level of income for each one of 
the country’s population) and the standardized incidence 
rate. There was a negative and no significant relationship 
between the standardized mortality rate of breast cancer 
and HDI. 
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